Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Aug;175(8):1191-1192.
doi: 10.7326/M22-1512. Epub 2022 Jun 7.

Cannabinoids for Chronic Pain: Translating Systematic Review Findings Into Clinical Action

Affiliations
Editorial

Cannabinoids for Chronic Pain: Translating Systematic Review Findings Into Clinical Action

Kevin F Boehnke et al. Ann Intern Med. 2022 Aug.
No abstract available

PubMed Disclaimer

Comment on

Similar articles

Cited by

References

    1. McDonagh MS, Morasco BJ, Wagner J, et al. Cannabis-based products for chronic pain. A systematic review. Ann Intern Med. 7 June 2022. [Epub ahead of print]. doi:10.7326/M21-4520 - DOI - PubMed
    1. O’Grady C Cannabis research database shows how U.S. funding focuses on harms of the drug. Science. 27 August 2020. Accessed at www.science.org/content/article/cannabis-research-database-shows-how-us-... on 10 May 2022.
    1. Boehnke KF, Gangopadhyay S, Clauw DJ, et al. Qualifying conditions of medical cannabis license holders in the United States. Health Aff (Millwood). 2019;38:295–302. doi:10.1377/hlthaff.2018.05266 - DOI - PMC - PubMed
    1. Reid M A qualitative review of cannabis stigmas at the twilight of prohibition. J Cannabis Res. 2020;2:46. doi:10.1186/s42238-020-00056-8 - DOI - PMC - PubMed
    1. Dahlgren MK, Sagar KA, Lambros AM, et al. Urinary tetrahydrocannabinol after 4 weeks of a full-spectrum, high-cannabidiol treatment in an open-label clinical trial [Letter]. JAMA Psychiatry. 2021;78:335–337. doi:10.1001/jamapsychiatry.2020.3567 - DOI - PMC - PubMed